HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccinia necrosum complicating immunoblastic sarcoma.

Abstract
A 59-year-old man is presented who had immunoblastic lymphadenopathy which evolved over a three-year period into immunoblastic sarcoma. His course was complicated by vaccinia necrosum, which necessitated prolonged therapy with Marboran and vaccinia-immune globulin. The persistence of virus was documented at autopsy by positive viral culture and ultra-structural examination. This case illustrates the potential hazards of administration of live viral vaccines to an immune compromised host presumed to be in remission and suggests that the continued activity of viral infection may signal the unsuspected persistence of underlying disease.
AuthorsS B Turkel, G D Overturf
JournalCancer (Cancer) Vol. 40 Issue 1 Pg. 226-33 (Jul 1977) ISSN: 0008-543X [Print] United States
PMID880554 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulins
  • Smallpox Vaccine
  • Thiosemicarbazones
Topics
  • Adult
  • Humans
  • Immune System Diseases (complications, pathology)
  • Immunoglobulins (therapeutic use)
  • Inclusion Bodies, Viral
  • Lymphatic Diseases (complications, pathology)
  • Male
  • Sarcoma (complications, pathology)
  • Smallpox Vaccine (adverse effects)
  • Thiosemicarbazones (therapeutic use)
  • Vaccinia (complications, pathology, therapy)
  • Vaccinia virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: